OpenVSafe by OpenVAERS
Search V-safe

VSM-18734-07945

2 vaccinations 2 coded responses 10 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
461 / IN
Registered
2021-04-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-08
    Registered in v-safe
  2. 2021-04-08
    Dose 1 — Moderna
  3. 2021-04-08
    Health check-in — 0 day, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  4. 2021-04-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-04-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Vomiting · Be unable to work
    Adult check-in
  8. 2021-04-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-04-22
    Survey response — 14 day, dose 1
    MedDRA: Pregnancy — Feeling: Fair
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  10. 2021-05-11
    Dose 2 — Moderna
  11. 2021-05-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work
    Adult check-in
  12. 2021-05-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Adult check-in
  13. 2021-05-14
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-05-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Conjunctivitis — Feeling: Fair · Site: Pain · Fatigue or tiredness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
  15. 2022-05-05
  16. 2022-05-10

Vaccinations

DoseDateManufacturerCo-administered
12021-04-08Moderna
22021-05-11Moderna

Call center

ReportedOutcomeVAERS-related outcome
2021-05-14 Unsuccessful

Free text

Release 7

Symptoms: Biochemical pregnancy

Release 8

Systemic reaction (other): Pink eye

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDPregnancy ✓ ✓ ✓
SROConjunctivitis ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release